Hepatology (Baltimore, Md.) 2023 May 22
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Related Questions
New answer by Medical Oncologist at Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty (May 25, 2025)
If not previously used, both Category 1, NCCN accepted first-line HCC regimens: atezolizumab plus bevacizumab and trelimumab plus durvalumab are reasonable to consider for sub...